Folgen
Ilyés Kinga
Titel
Zitiert von
Zitiert von
Jahr
The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with …
K Ilyés, NK Kovács, A Balogh, E Borbás, B Farkas, T Casian, G Marosi, ...
European Journal of Pharmaceutical Sciences 129, 110-123, 2019
1362019
3D floating tablets: Appropriate 3D design from the perspective of different in vitro dissolution testing methodologies
K Ilyés, A Balogh, T Casian, T Igricz, E Borbás, B Démuth, P Vass, ...
International journal of pharmaceutics 567, 118433, 2019
402019
Electrospun amorphous solid dispersions of meloxicam: Influence of polymer type and downstream processing to orodispersible dosage forms
T Casian, E Borbás, K Ilyés, B Démuth, A Farkas, Z Rapi, C Bogdan, ...
International journal of pharmaceutics 569, 118593, 2019
392019
Data fusion strategies for performance improvement of a Process Analytical Technology platform consisting of four instruments: An electrospinning case study
T Casian, A Farkas, K Ilyés, B Démuth, E Borbás, L Madarász, Z Rapi, ...
International Journal of Pharmaceutics 567, 118473, 2019
172019
THREE-DIMENSIONAL PRINTING BY FUSED DEPOSITION MODELING (3DP-FDM) IN PHARMACEUTICS.
K Ilyes, AG CRIŞAN, A Porfire, I TOMUȚĂ
Farmacia 68 (4), 2020
122020
Applying the principles of Quality by Design (QbD) coupled with multivariate data analysis (MVDA) in establishing the impact of raw material variability for extended release …
K ILYÉS, T CASIAN, D HALES, G BORODI, L RUS, R ȘTIUFIUC, ...
Farmacia 69 (3), 481 - 497, 2021
92021
The future of pharmaceutics: 3D-printing?
K Ilyés
Ro J Pharm Prac 13 (4), 188-192, 2020
12020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–7